Table 5.
Comparative description of patients with obesity treated with diet supplemented with Aloe ferox vs supplemented with placebo, after three months of treatment.
| Parameters | Aloe ferox (n = 17) | Placebo (n = 20) | P value |
| BMI (kg/m2) | 30.94 ± 2.56 | 32.20 ± 3.85 | .030 |
| AC (cm) | 110.50 ± 10.29 | 111.95 ± 10.08 | .603 |
| TC (mg %) | 154.52 ± 28.87 | 154.35 ± 26.56 | .032 |
| HDLc (mg %) | 48.88 ± 8.48 | 49.00 ± 8.60 | .894 |
| LDLc (mg %) | 74.44 ± 27.81 | 75.70 ± 26.13 | .010 |
| TG (mg %) | 156.00 ± 76.81 | 148.25 ± 73.41 | .490 |
| Fasting glycemia (mg %) | 94.35 ± 4.59 | 94.10 ± 4.33 | .018 |
| Uric acid (mg%) | 5.90 ± 1.46 | 5.83 ± 1.61 | .897 |
| Systolic blood pressure (mm Hg) | 127.94 ± 15.41 | 127.25 ± 14.37 | .359 |
| Diastolic blood pressure (mm Hg) | 71.47 ± 8.43 | 70.75 ± 8.15 | .298 |
aContinuous variables (with Gaussian distribution) are indicated by their mean (±st.dev.).
bCategorical variables are presented by percentage (absolute frequency) in the sample.
AC = abdominal circumference, BMI = body mass index, HDLc = high-density lipoprotein cholesterol, LDLc = low-density lipoprotein cholesterol, TC = total cholesterol, TG = triglycerides.